Navigation

    Forum

    • Register
    • Login
    • Search
    • Categories
    • Recent
    • Popular
    • Users
    • Groups

    280 - Is including the names of Rx products on sales rep business cards and email signatures allowed ? Or are these considered APS or potentially DTC advertising . Thank you

    DTCA/I, consumer secondary audience
    1
    1
    101
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • Jennifer Carroll
      Jennifer Carroll last edited by

      It appears that there is a chance that these cards will fall into the hands of consumers. We must therefore consider consumer regulations. The name of the drug alone would not exceed consumer regulations (provided the drug is not a narcotic or a controlled drug as consumer promotion of such products is completely prohibited). However, inclusion of anything which would allude to the therapeutic use of the listed drug (e.g. a drug rep title such as "Neuroscience Specialty Mood Representative") would exceed consumer restrictions for prescription products and for products used for the treatment of a schedule A disease. It is advisable to limit distribution to HCPs if including anything beyond the company name/address, the drug rep name & contact info, and a generic title such as "Product Representative". Should distribution be limited to HCPs as they contained specific drug rep types, PAAB would review these as corporate pieces with product mention. All cards across the company's product offerings may be submitted as a single piece. For each product we'd ensure the implied therapeutic classification is accurate and on-label. Note that inclusion of product claims would require fair balance.

      1 Reply Last reply Reply Quote 0
      • First post
        Last post